Nootkatone, a characteristic constituent of grapefruit, stimulates energy metabolism and prevents diet-induced obesity by activating AMPK
Open Access
- 1 August 2010
- journal article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 299 (2), E266-E275
- https://doi.org/10.1152/ajpendo.00774.2009
Abstract
AMP-activated protein kinase (AMPK) is a serine/threonine kinase that is implicated in the control of energy metabolism and is considered to be a molecular target for the suppression of obesity and the treatment of metabolic syndrome. Here, we identified and characterized nootkatone, a constituent of grapefruit, as a naturally occurring AMPK activator. Nootkatone induced an increase in AMPKα1 and -α2 activity along with an increase in the AMP/ATP ratio and an increase the phosphorylation of AMPKα and the downstream target acetyl-CoA carboxylase (ACC), in C2C12 cells. Nootkatone-induced activation of AMPK was possibly mediated both by LKB1 and Ca2+/calmodulin-dependent protein kinase kinase. Nootkatone also upregulated PPARγ coactivator-1α in C2C12 cells and C57BL/6J mouse muscle. In addition, administration of nootkatone (200 mg/kg body wt) significantly enhanced AMPK activity, accompanied by LKB1, AMPK, and ACC phosphorylation in the liver and muscle of mice. Whole body energy expenditure evaluated by indirect calorimetry was also increased by nootkatone administration. Long-term intake of diets containing 0.1% to 0.3% (wt/wt) nootkatone significantly reduced high-fat and high-sucrose diet-induced body weight gain, abdominal fat accumulation, and the development of hyperglycemia, hyperinsulinemia, and hyperleptinemia in C57BL/6J mice. Furthermore, endurance capacity, evaluated as swimming time to exhaustion in BALB/c mice, was 21% longer in mice fed 0.2% nootkatone than in control mice. These findings indicate that long-term intake of nootkatone is beneficial toward preventing obesity and improving physical performance and that these effects are due, at least in part, to enhanced energy metabolism through AMPK activation in skeletal muscle and liver.Keywords
This publication has 39 references indexed in Scilit:
- C-terminal Phosphorylation of LKB1 Is Not Required for Regulation of AMP-activated Protein Kinase, BRSK1, BRSK2, or Cell Cycle ArrestOnline Journal of Public Health Informatics, 2009
- Suppression of the aging-associated decline in physical performance by a combination of resveratrol intake and habitual exercise in senescence-accelerated miceBiogerontology, 2008
- AMPK and PPARδ Agonists Are Exercise MimeticsCell, 2008
- Reactive Nitrogen Species Is Required for the Activation of the AMP-activated Protein Kinase by Statin in VivoPublished by Elsevier BV ,2008
- Phosphorylation of LKB1 at Serine 428 by Protein Kinase C-ζ Is Required for Metformin-Enhanced Activation of the AMP-Activated Protein Kinase in Endothelial CellsCirculation, 2008
- AMP-activated protein kinase signaling in metabolic regulationJCI Insight, 2006
- The role of AMP‐activated protein kinase in mitochondrial biogenesisThe Journal of Physiology, 2006
- Regulation of Muscle Fiber Type and Running Endurance by PPARδPLoS Biology, 2004
- Role of AMP-activated protein kinase in mechanism of metformin actionJCI Insight, 2001
- Peutz-Jeghers syndrome is caused by mutations in a novel serine threoninekinaseNature Genetics, 1998